Gene: KDM4A
Official Full Name: lysine demethylase 4Aprovided by HGNC
Gene Summary: This gene is a member of the Jumonji domain 2 (JMJD2) family and encodes a protein containing a JmjN domain, a JmjC domain, a JD2H domain, two TUDOR domains, and two PHD-type zinc fingers. This nuclear protein functions as a trimethylation-specific demethylase, converting specific trimethylated histone residues to the dimethylated form, and as a transcriptional repressor. [provided by RefSeq, Apr 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03934 | KDM4A Knockout cell line (HeLa) | Human | KDM4A | 1:3~1:6 | Negative | Online Inquiry |
KO03935 | KDM4A Knockout cell line (HCT 116) | Human | KDM4A | 1:2~1:4 | Negative | Online Inquiry |
KO03936 | KDM4A Knockout cell line (HEK293) | Human | KDM4A | 1:3~1:6 | Negative | Online Inquiry |
KO03937 | KDM4A Knockout cell line (A549) | Human | KDM4A | 1:3~1:4 | Negative | Online Inquiry |
KDM4A Gene Knockout Cell Lines are specialized cellular models engineered to lack the expression of the KDM4A gene, which encodes a lysine demethylase involved in the regulation of gene expression through histone modification. These cell lines are strategically designed to facilitate the study of KDM4A's biological functions, including its role in chromatin remodeling, gene transcription regulation, and cellular signaling pathways. By eliminating KDM4A function, researchers can delve deeper into the gene's involvement in processes such as cellular differentiation, proliferation, and the epigenetic basis of various diseases, including cancer.
The key mechanism by which these knockout cell lines operate lies in their ability to mimic the conditions of KDM4A deficiency, allowing for the assessment of downstream effects on gene expression and associated phenotypic changes. This model serves as a crucial tool in elucidating the complex interactions between epigenetic regulation and other cellular processes, providing invaluable insights that can lead to innovative therapeutic strategies.
The scientific importance of KDM4A Gene Knockout Cell Lines cannot be overstated, particularly in cancer research, where aberrant expression of histone demethylases has been linked to oncogenesis. These cell lines have applications in drug discovery, functional genomics, and the investigation of therapeutic resistance mechanisms, making them indispensable for advancing our understanding of epigenetic contributions to disease.
Compared to alternative models such as wild-type cell lines or transient knockdown approaches, the KDM4A Gene Knockout Cell Lines offer a stable and reproducible system for long-term studies. Their robust and consistent genetic modification ensures that experimental results are reliable and can be reliably reproduced across multiple research endeavors.
For researchers and clinicians seeking to explore the multifaceted roles of KDM4A in health and disease, these knockout cell lines provide a valuable resource that can significantly enhance experimental outcomes. With our company’s longstanding expertise and commitment to innovation in the field of biological research tools, we are dedicated to delivering high-quality products that empower scientific discovery and improve clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.